A significant advance in cancer study is emerging with the use of mini-antibodies to restore mutated p53. This essential malignant protector protein is frequently lost in many kinds of malignancies, resulting https://bookmark-template.com/story30165187/nanobodies-reactivate-the-p53-protein-the-new-hope-for-tumor-management